Chronic Hepatitis D Infection clinical trials

Explore recruiting chronic hepatitis d infection clinical trials.

Recruiting chronic hepatitis d infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Hepatitis D Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study)

Germany, Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection

France, Austria, Germany, Romania, Belgium, Spain +1 more

Therapeutic use (Phase IV) EU CTIS Study details

A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Austria, Italy, Czechia, Romania, Sweden, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2b/3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelovitug for the Treatment of Chronic Hepatitis Delta Infection in Participants Receiving Bulevirtide (AZURE-3)

Czechia, Austria, Spain, Romania, Germany, Italy +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 1/2a, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Healthy Volunteers and in Subjects with Chronic Hepatitis B Infection, Including Subjects with Chronic Hepatitis D Infection

Bulgaria, Romania, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Chronic Hepatitis D Infection trials by city

Chronic Hepatitis D Infection in Toronto Chronic Hepatitis D Infection in Vancouver Chronic Hepatitis D Infection in Montreal Chronic Hepatitis D Infection in Calgary Chronic Hepatitis D Infection in Edmonton Chronic Hepatitis D Infection in Ottawa Chronic Hepatitis D Infection in Winnipeg Chronic Hepatitis D Infection in Quebec City Chronic Hepatitis D Infection in Hamilton Chronic Hepatitis D Infection in Kitchener Chronic Hepatitis D Infection in London Chronic Hepatitis D Infection in Halifax Chronic Hepatitis D Infection in New York Chronic Hepatitis D Infection in Los Angeles Chronic Hepatitis D Infection in Chicago Chronic Hepatitis D Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease